MyFinsight
Home
About
Contact
crvs: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, CRVS has $80,474K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Buy me a coffee
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
80,474
89,461
Total stockholders' equity
71,768
80,228
Total liabilities and stockholders' equity
80,474
89,461
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Subscribe for Financial Insights
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Prepaid and other
current assets
$1,223K
Accounts receivable -
related party
$32K
Marketable securities
$62,822K
Cash and cash
equivalents
$2,867K
Other assets
$852K
Investment in angel
pharmaceuticals
$11,530K
Operating lease
right-of-use asset
$927K
Property and equipment,
net
$221K
Total current assets
$66,944K
Total assets
$80,474K
Total liabilities and
stockholders' equity
$80,474K
Total stockholders'
equity
$71,768K
Total liabilities
$8,706K
Accumulated deficit
-$399,972K
Accumulated other
comprehensive loss
-$1,060K
Additional paid-in capital
$472,793K
Operating lease liability
$632K
Total current
liabilities
$8,074K
Common stock 0.0001 par
value 290,000,000...
$7K
Accrued and other
liabilities
$5,721K
Operating lease liability
$379K
Accounts payable
$1,974K
Subscribe for Financial Insights
Corvus Pharmaceuticals, Inc. (CRVS)
Corvus Pharmaceuticals, Inc. (CRVS)